O	O	0	7	Epstein	Epstein	B-NP	NNP	O	3	NMOD	O
O	O	7	8	-	-	I-NP	HYPH	O	3	P	O
O	O	8	12	Barr	Barr	I-NP	NNP	O	5	NMOD	O
O	O	13	18	viral	viral	I-NP	JJ	O	5	NMOD	O
O	O	19	26	latency	latency	I-NP	NN	O	6	SUB	O
O	O	27	29	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	30	39	disrupted	disrupt	I-VP	VBN	O	6	VC	O
O	O	40	42	by	by	B-PP	IN	O	7	VMOD	O
O	O	43	46	the	the	B-NP	DT	O	14	NMOD	O
O	O	47	56	immediate	immediate	I-NP	JJ	B-protein	14	NMOD	B-protein
O	O	56	57	-	-	I-NP	HYPH	I-protein	14	NMOD	I-protein
O	O	57	62	early	early	I-NP	JJ	I-protein	14	NMOD	I-protein
T1	B-Protein	63	68	BRLF1	BRLF1	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	69	76	protein	protein	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	77	84	through	through	B-PP	IN	O	7	VMOD	O
O	O	85	86	a	a	B-NP	DT	O	20	NMOD	O
O	O	87	91	cell	cell	I-NP	NN	O	20	NMOD	O
O	O	91	92	-	-	B-NP	HYPH	O	20	NMOD	O
O	O	92	100	specific	specific	I-NP	JJ	O	20	NMOD	O
O	O	101	110	mechanism	mechanism	I-NP	NN	O	15	PMOD	O
O	O	110	111	.	.	O	.	O	6	P	O

O	O	113	120	Epstein	Epstein	B-NP	NNP	O	11	NMOD	O
O	O	120	121	-	-	I-NP	HYPH	O	11	NMOD	O
O	O	121	125	Barr	Barr	I-NP	NNP	O	4	NMOD	O
O	O	126	131	virus	virus	I-NP	NN	O	11	NMOD	O
O	O	132	133	(	(	O	(	O	7	DEP	O
O	O	133	136	EBV	EBV	B-NP	NN	O	7	DEP	O
O	O	136	137	)	)	O	)	O	4	NMOD	O
O	O	137	138	,	,	O	,	O	11	P	O
O	O	139	142	the	the	B-NP	DT	O	11	NMOD	O
O	O	143	152	causative	causative	I-NP	JJ	O	11	NMOD	O
O	O	153	158	agent	agent	I-NP	NN	O	16	SUB	O
O	O	159	161	of	of	B-PP	IN	O	11	NMOD	O
O	O	162	172	infectious	infectious	B-NP	JJ	O	14	NMOD	O
O	O	173	186	mononucleosis	mononucleosis	I-NP	NN	O	12	PMOD	O
O	O	186	187	,	,	O	,	O	11	P	O
O	O	188	190	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	191	192	a	a	B-NP	DT	O	19	NMOD	O
O	O	193	198	human	human	I-NP	JJ	O	19	NMOD	O
O	O	199	210	herpesvirus	herpesvirus	I-NP	NN	O	16	PRD	O
O	O	211	221	associated	associate	B-VP	VBN	O	19	NMOD	O
O	O	222	226	with	with	B-PP	IN	O	20	VMOD	O
O	O	227	237	epithelial	epithelial	B-NP	JJ	O	24	NMOD	O
O	O	238	242	cell	cell	I-NP	NN	O	24	NMOD	O
O	O	243	255	malignancies	malignancy	I-NP	NNS	O	35	NMOD	O
O	O	256	257	(	(	O	(	O	28	DEP	O
O	O	257	271	nasopharyngeal	nasopharyngeal	B-NP	JJ	O	27	NMOD	O
O	O	272	281	carcinoma	carcinoma	I-NP	NN	O	28	DEP	O
O	O	281	282	)	)	O	)	O	24	NMOD	O
O	O	283	285	as	as	B-CONJP	RB	O	35	NMOD	O
O	O	286	290	well	well	I-CONJP	RB	O	29	DEP	O
O	O	291	293	as	as	I-CONJP	IN	O	29	DEP	O
O	O	294	295	B	B	B-NP	NN	O	35	NMOD	O
O	O	295	296	-	-	I-NP	HYPH	O	35	P	O
O	O	296	300	cell	cell	I-NP	NN	O	35	NMOD	O
O	O	301	313	malignancies	malignancy	I-NP	NNS	O	21	PMOD	O
O	O	313	314	.	.	O	.	O	16	P	O

O	O	315	328	Understanding	Understand	B-VP	VBG	O	7	SUB	O
O	O	329	332	how	how	B-ADVP	WRB	O	1	VMOD	O
O	O	333	338	viral	viral	B-NP	JJ	O	4	NMOD	O
O	O	339	346	latency	latency	I-NP	NN	O	5	SUB	O
O	O	347	349	is	be	B-VP	VBZ	O	2	SBAR	O
O	O	350	359	disrupted	disrupt	I-VP	VBN	O	5	VC	O
O	O	360	362	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	363	364	a	a	B-NP	DT	O	10	NMOD	O
O	O	365	372	central	central	I-NP	JJ	O	10	NMOD	O
O	O	373	378	issue	issue	I-NP	NN	O	7	PRD	O
O	O	379	381	in	in	B-PP	IN	O	10	NMOD	O
O	O	382	393	herpesvirus	herpesvirus	B-NP	NN	O	13	NMOD	O
O	O	394	401	biology	biology	I-NP	NN	O	11	PMOD	O
O	O	401	402	.	.	O	.	O	7	P	O

O	O	403	413	Epithelial	Epithelial	B-NP	JJ	B-cell_type	2	NMOD	B-cell_type
O	O	414	419	cells	cell	I-NP	NNS	I-cell_type	3	SUB	I-cell_type
O	O	420	423	are	be	B-VP	VBP	O	19	VMOD	O
O	O	424	427	the	the	B-NP	DT	O	6	NMOD	O
O	O	428	433	major	major	I-NP	JJ	O	6	NMOD	O
O	O	434	438	site	site	I-NP	NN	O	3	PRD	O
O	O	439	441	of	of	B-PP	IN	O	6	NMOD	O
O	O	442	447	lytic	lytic	B-NP	JJ	O	10	NMOD	O
O	O	448	451	EBV	EBV	I-NP	NN	O	10	NMOD	O
O	O	452	463	replication	replication	I-NP	NN	O	7	PMOD	O
O	O	464	470	within	within	B-PP	IN	O	6	NMOD	O
O	O	471	474	the	the	B-NP	DT	O	14	NMOD	O
O	O	475	480	human	human	I-NP	JJ	O	14	NMOD	O
O	O	481	485	host	host	I-NP	NN	O	11	PMOD	O
O	O	485	486	,	,	O	,	O	19	P	O
O	O	487	490	and	and	O	CC	O	19	VMOD	O
O	O	491	496	viral	viral	B-NP	JJ	O	18	NMOD	O
O	O	497	509	reactivation	reactivation	I-NP	NN	O	19	SUB	O
O	O	510	516	occurs	occur	B-VP	VBZ	O	0	ROOT	O
O	O	517	519	in	in	B-PP	IN	O	19	VMOD	O
O	O	520	523	EBV	EBV	B-NP	NN	O	25	NMOD	O
O	O	523	524	-	-	O	HYPH	O	25	P	O
O	O	524	534	associated	associate	B-NP	VBN	O	25	NMOD	O
O	O	535	549	nasopharyngeal	nasopharyngeal	I-NP	JJ	O	25	NMOD	O
O	O	550	560	carcinomas	carcinoma	I-NP	NNS	O	20	PMOD	O
O	O	560	561	.	.	O	.	O	19	P	O

O	O	562	564	It	It	B-NP	PRP	O	2	SUB	O
O	O	565	567	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	568	573	known	know	I-VP	VBN	O	2	VC	O
O	O	574	578	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	579	589	expression	expression	B-NP	NN	O	17	SUB	O
O	O	590	592	of	of	B-PP	IN	O	5	NMOD	O
O	O	593	594	a	a	B-NP	DT	O	13	NMOD	O
O	O	595	601	single	single	I-NP	JJ	O	13	NMOD	O
O	O	602	607	viral	viral	I-NP	JJ	B-protein	13	NMOD	B-protein
O	O	608	617	immediate	immediate	I-NP	JJ	I-protein	13	NMOD	I-protein
O	O	617	618	-	-	I-NP	HYPH	I-protein	13	NMOD	I-protein
O	O	618	623	early	early	I-NP	JJ	I-protein	13	NMOD	I-protein
O	O	624	631	protein	protein	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	631	632	,	,	O	,	O	15	P	O
T2	B-Protein	633	638	BZLF1	BZLF1	B-NP	NN	B-protein	6	PMOD	B-protein
O	O	638	639	,	,	O	,	O	15	P	O
O	O	640	642	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	643	653	sufficient	sufficient	B-ADJP	JJ	O	17	PRD	O
O	O	654	656	to	to	B-VP	TO	O	20	VMOD	O
O	O	657	665	initiate	initiate	I-VP	VB	O	18	AMOD	O
O	O	666	669	the	the	B-NP	DT	O	22	NMOD	O
O	O	670	676	switch	switch	I-NP	NN	O	27	NMOD	O
O	O	677	681	from	from	B-PP	IN	O	27	NMOD	O
O	O	682	688	latent	latent	B-ADJP	JJ	O	23	PMOD	O
O	O	689	691	to	to	B-PP	TO	O	27	NMOD	O
O	O	692	697	lytic	lytic	B-NP	JJ	O	25	PMOD	O
O	O	698	707	infection	infection	I-NP	NN	O	20	OBJ	O
O	O	708	710	in	in	B-PP	IN	O	27	NMOD	O
O	O	711	712	B	B	B-NP	NN	B-cell_type	30	NMOD	B-cell_type
O	O	713	718	cells	cell	I-NP	NNS	I-cell_type	28	PMOD	I-cell_type
O	O	718	719	.	.	O	.	O	2	P	O

O	O	720	728	Cellular	Cellular	B-NP	JJ	O	2	NMOD	O
O	O	729	739	regulation	regulation	I-NP	NN	O	6	SUB	O
O	O	740	742	of	of	B-PP	IN	O	2	NMOD	O
T3	B-Protein	743	748	BZLF1	BZLF1	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	749	762	transcription	transcription	I-NP	NN	O	3	PMOD	O
O	O	763	765	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	766	775	therefore	therefore	I-VP	RB	O	6	VMOD	O
O	O	776	783	thought	think	I-VP	VBN	O	6	VC	O
O	O	784	786	to	to	I-VP	TO	O	10	VMOD	O
O	O	787	791	play	play	I-VP	VB	O	8	VMOD	O
O	O	792	793	a	a	B-NP	DT	O	13	NMOD	O
O	O	794	797	key	key	I-NP	JJ	O	13	NMOD	O
O	O	798	802	role	role	I-NP	NN	O	10	OBJ	O
O	O	803	805	in	in	B-PP	IN	O	10	VMOD	O
O	O	806	816	regulating	regulate	B-VP	VBG	O	14	PMOD	O
O	O	817	820	the	the	B-NP	DT	O	17	NMOD	O
O	O	821	831	stringency	stringency	I-NP	NN	O	15	OBJ	O
O	O	832	834	of	of	B-PP	IN	O	17	NMOD	O
O	O	835	840	viral	viral	B-NP	JJ	O	20	NMOD	O
O	O	841	848	latency	latency	I-NP	NN	O	18	PMOD	O
O	O	848	849	.	.	O	.	O	6	P	O

O	O	850	854	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	855	857	we	we	B-NP	PRP	O	3	SUB	O
O	O	858	862	show	show	B-VP	VBP	O	0	ROOT	O
O	O	863	867	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	867	868	,	,	O	,	O	4	P	O
O	O	869	881	unexpectedly	unexpectedly	B-ADVP	RB	O	19	VMOD	O
O	O	881	882	,	,	O	,	O	19	P	O
O	O	883	893	expression	expression	B-NP	NN	O	19	SUB	O
O	O	894	896	of	of	B-PP	IN	O	8	NMOD	O
O	O	897	904	another	another	B-NP	DT	O	15	NMOD	O
O	O	905	910	viral	viral	I-NP	JJ	B-protein	15	NMOD	B-protein
O	O	911	920	immediate	immediate	I-NP	JJ	I-protein	15	NMOD	I-protein
O	O	920	921	-	-	I-NP	HYPH	I-protein	15	NMOD	I-protein
O	O	921	926	early	early	I-NP	JJ	I-protein	15	NMOD	I-protein
O	O	927	934	protein	protein	I-NP	NN	I-protein	17	NMOD	I-protein
O	O	934	935	,	,	O	,	O	17	P	O
T4	B-Protein	936	941	BRLF1	BRLF1	B-NP	NN	B-protein	9	PMOD	B-protein
O	O	941	942	,	,	O	,	O	17	P	O
O	O	943	946	can	can	B-VP	MD	O	4	SBAR	O
O	O	947	954	disrupt	disrupt	I-VP	VB	O	19	VC	O
O	O	955	960	viral	viral	B-NP	JJ	O	22	NMOD	O
O	O	961	968	latency	latency	I-NP	NN	O	20	OBJ	O
O	O	969	971	in	in	B-PP	IN	O	20	VMOD	O
O	O	972	974	an	an	B-NP	DT	O	29	NMOD	O
O	O	975	985	epithelial	epithelial	I-NP	JJ	B-cell_type	26	NMOD	B-cell_type
O	O	986	990	cell	cell	I-NP	NN	I-cell_type	29	NMOD	I-cell_type
O	O	990	991	-	-	B-NP	HYPH	O	29	NMOD	O
O	O	991	999	specific	specific	I-NP	JJ	O	29	NMOD	O
O	O	1000	1007	fashion	fashion	I-NP	NN	O	23	PMOD	O
O	O	1007	1008	.	.	O	.	O	3	P	O

O	O	1009	1018	Therefore	Therefore	B-ADVP	RB	O	11	VMOD	O
O	O	1018	1019	,	,	O	,	O	11	P	O
O	O	1020	1023	the	the	B-NP	DT	O	4	NMOD	O
O	O	1024	1034	mechanisms	mechanism	I-NP	NNS	O	11	SUB	O
O	O	1035	1042	leading	lead	B-VP	VBG	O	4	NMOD	O
O	O	1043	1045	to	to	B-PP	TO	O	5	VMOD	O
O	O	1046	1056	disruption	disruption	B-NP	NN	O	6	PMOD	O
O	O	1057	1059	of	of	B-PP	IN	O	7	NMOD	O
O	O	1060	1063	EBV	EBV	B-NP	NN	O	10	NMOD	O
O	O	1064	1071	latency	latency	I-NP	NN	O	8	PMOD	O
O	O	1072	1078	appear	appear	B-VP	VBP	O	0	ROOT	O
O	O	1079	1081	to	to	I-VP	TO	O	13	VMOD	O
O	O	1082	1084	be	be	I-VP	VB	O	11	VMOD	O
O	O	1085	1089	cell	cell	B-NP	NN	O	16	AMOD	O
O	O	1089	1090	-	-	B-NP	HYPH	O	14	P	O
O	O	1090	1094	type	type	I-NP	NN	O	13	PRD	O
O	O	1095	1103	specific	specific	B-ADJP	JJ	O	16	AMOD	O
O	O	1103	1104	.	.	O	.	O	11	P	O
